{
  "docId": "019de075-4481-714f-9573-a4ad96e0f148",
  "docSlug": "816ee2fbc8fb2bf52edc4f2891aaa98f",
  "documentTitle": "Dare Bioscience | Investor Presentation Deck | 27 slides",
  "authorId": "dare-bioscience",
  "authorName": "Daré Bioscience",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.2938006,
  "pageNumber": 2,
  "pageCount": 27,
  "prevPage": 1,
  "nextPage": 3,
  "slideType": "disclaimer",
  "function": "other",
  "density": "dense",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-4481-714f-9573-a4ad96e0f148/2",
  "deckHref": "/decks/019de075-4481-714f-9573-a4ad96e0f148",
  "deckJsonHref": "/decks/019de075-4481-714f-9573-a4ad96e0f148.json",
  "deckAnchorHref": "/decks/019de075-4481-714f-9573-a4ad96e0f148#slide-2",
  "components": [
    {
      "bbox": {
        "h": 0.045,
        "w": 0.804,
        "x": 0.098,
        "y": 0.815
      },
      "kind": "disclaimer",
      "text": "All trademarks, service marks or trade names appearing in this presentation are the property of their respective owners. Unless specifically identified as such, Daré’s use or display of third-party marks is not intended and does not indicate or imply any relationship with or endorsement or sponsorship of Daré by the third-party owner.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2162c253-621f-49ad-bb89-ae061be7c480",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.065,
        "w": 0.804,
        "x": 0.098,
        "y": 0.266
      },
      "kind": "disclaimer",
      "text": "This presentation is for informational purposes only and is not an offer to sell or a solicitation of an offer to buy any securities of Daré Bioscience, Inc. (\"Daré\" or the \"Company\"). This presentation includes certain information obtained from trade and statistical services, third-party publications, and other sources. Daré has not independently verified such information and there can be no assurance as to its accuracy.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3497c70d-7c40-4c0e-8372-92aad3901dcc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.455,
        "w": 0.804,
        "x": 0.098,
        "y": 0.345
      },
      "kind": "disclaimer",
      "text": "All statements in this presentation, other than statements of historical fact, are forward-looking statements within the meaning of federal securities laws. In some cases, you can identify forward-looking statements by terms such as \"may,\" \"will,\" \"expect,\" \"plan,\" \"anticipate,\" \"strategy,\" \"designed,\" \"could,\" \"intend,\" \"believe,\" \"estimate,\" \"target,\" or \"potential,\" or the negative of these terms and other similar expressions. Such statements include, but are not limited to, statements relating to anticipated clinical development, target product profiles and indications, and regulatory approval pathway for Daré’s product candidates, anticipated timing of commercial launch of XACIATO™ (clindamycin phosphate) vaginal gel, 2%, Sildenafil Cream’s potential as a safe and effective therapy for FSAD and FSIAD, the potential for Sildenafil Cream to be the first FDA-approved treatment for FSAD and/or FSIAD, and the potential market opportunity for Sildenafil Cream. Forward-looking statements reflect management’s estimates and expectations based on current information and involve risks, uncertainties and assumptions that may cause Daré’s actual results, performance or achievements to be materially different from those expressed or implied by the forward-looking statements, including, without limitation: the risk that topline results from a clinical trial, including the Phase 2b RESPOND study of Sildenafil Cream, are based on Daré’s preliminary analysis of key efficacy and safety data and, following a comprehensive review of the study data, topline results may not accurately reflect the complete results from the study and the differences between topline results and complete results may be significant and may adversely impact the continued clinical development of the investigational product, including anticipated time and expense of continued development; the risk that positive data from the Phase 2b RESPOND study may not be predictive of results of any future clinical study; the risk that the FDA, other regulatory authorities, members of the scientific or medical communities or investors may not accept or agree with Daré’s interpretation of or conclusions regarding the Phase 2b RESPOND study data; Daré’s reliance on third parties to commercialize XACIATO and to manufacture and conduct clinical trials of its product and product candidates; the degree of market acceptance that XACIATO and any future product achieves; risks and uncertainties inherent in Daré’s ability to successfully develop, obtain regulatory approval and monetize its product candidates; Daré’s need for additional capital to fund operations and execute its business strategy; and those risks and uncertainties described in Daré’s most recent annual report on Form 10-K filed with the Securities and Exchange Commission under the heading \"Risk Factors.\" All forward-looking statements are current only as of the date of this presentation. Daré does not undertake any obligation to update any forward-looking statement in this presentation to reflect new information, future developments or otherwise, except as required by law.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ab7c02ad-2100-464e-b852-832856ea2272",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.025,
        "w": 0.415,
        "x": 0.128,
        "y": 0.198
      },
      "kind": "title",
      "text": "Forward-Looking Statements; Disclaimers",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a15ac49a-5894-44bd-a1c0-81e2dcc82233",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}